Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves’ disease

Antithyroid drugs are generally selected as the first-line treatment for Graves’ Disease (GD); however, the existence of patients showing resistance or severe side effects to these drugs is an important issue to be solved. The (pro)renin receptor [(P)RR] is a multi-functional protein that activates...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuguchi, Yuki, Morimoto, Satoshi, Kimura, Shihori, Takano, Noriyoshi, Yamashita, Kaoru, Seki, Yasufumi, Bokuda, Kanako, Yatabe, Midori, Yatabe, Junichi, Watanabe, Daisuke, Ando, Takashi, Ichihara, Atsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886569/
https://www.ncbi.nlm.nih.gov/pubmed/29621332
http://dx.doi.org/10.1371/journal.pone.0195464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886569/
https://www.ncbi.nlm.nih.gov/pubmed/29621332
http://dx.doi.org/10.1371/journal.pone.0195464

Ejemplares similares